Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. / Dalbøge, C S; Hansen, C R; Pressler, T; Høiby, N; Johansen, H K.

In: Journal of Cystic Fibrosis, Vol. 10, No. 5, 01.09.2011, p. 318-25.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Dalbøge, CS, Hansen, CR, Pressler, T, Høiby, N & Johansen, HK 2011, 'Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis', Journal of Cystic Fibrosis, vol. 10, no. 5, pp. 318-25. https://doi.org/10.1016/j.jcf.2011.03.006, https://doi.org/10.1016/j.jcf.2011.03.006

APA

Dalbøge, C. S., Hansen, C. R., Pressler, T., Høiby, N., & Johansen, H. K. (2011). Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis, 10(5), 318-25. https://doi.org/10.1016/j.jcf.2011.03.006, https://doi.org/10.1016/j.jcf.2011.03.006

Vancouver

Dalbøge CS, Hansen CR, Pressler T, Høiby N, Johansen HK. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis. 2011 Sep 1;10(5):318-25. https://doi.org/10.1016/j.jcf.2011.03.006, https://doi.org/10.1016/j.jcf.2011.03.006

Author

Dalbøge, C S ; Hansen, C R ; Pressler, T ; Høiby, N ; Johansen, H K. / Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. In: Journal of Cystic Fibrosis. 2011 ; Vol. 10, No. 5. pp. 318-25.

Bibtex

@article{649b27fc91b8452d859ce9ae1232140b,
title = "Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis",
abstract = "Background The clinical consequences of chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patient are still unclear. Method All patients treated in the Copenhagen CF centre (N=278) from 1 January 2008 to 31 December 2009 were included. Each patient chronically infected with S. maltophilia for at least 2years without any other chronic Gram-negative infection were matched to two non-infected CF controls. Results Twenty-one patients were chronically infected with S. maltophilia during the 2-year study period. Fifteen were infected for at least 2years. The patients in the S. maltophilia group had a steeper decline (-3.2%/year vs. -0.3%/year) in FEV1 compared to the non-infected CF controls (P=0.03). The rate of decline was the same as observed 3years before the patients became chronically infected. Discussions Chronic infection with S. maltophilia does not lead to a steeper decline in lung function when compared to the period before chronic infection. ",
author = "Dalb{\o}ge, {C S} and Hansen, {C R} and T Pressler and N H{\o}iby and Johansen, {H K}",
note = "Copyright {\textcopyright} 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.",
year = "2011",
month = sep,
day = "1",
doi = "10.1016/j.jcf.2011.03.006",
language = "English",
volume = "10",
pages = "318--25",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis

AU - Dalbøge, C S

AU - Hansen, C R

AU - Pressler, T

AU - Høiby, N

AU - Johansen, H K

N1 - Copyright © 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Background The clinical consequences of chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patient are still unclear. Method All patients treated in the Copenhagen CF centre (N=278) from 1 January 2008 to 31 December 2009 were included. Each patient chronically infected with S. maltophilia for at least 2years without any other chronic Gram-negative infection were matched to two non-infected CF controls. Results Twenty-one patients were chronically infected with S. maltophilia during the 2-year study period. Fifteen were infected for at least 2years. The patients in the S. maltophilia group had a steeper decline (-3.2%/year vs. -0.3%/year) in FEV1 compared to the non-infected CF controls (P=0.03). The rate of decline was the same as observed 3years before the patients became chronically infected. Discussions Chronic infection with S. maltophilia does not lead to a steeper decline in lung function when compared to the period before chronic infection.

AB - Background The clinical consequences of chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patient are still unclear. Method All patients treated in the Copenhagen CF centre (N=278) from 1 January 2008 to 31 December 2009 were included. Each patient chronically infected with S. maltophilia for at least 2years without any other chronic Gram-negative infection were matched to two non-infected CF controls. Results Twenty-one patients were chronically infected with S. maltophilia during the 2-year study period. Fifteen were infected for at least 2years. The patients in the S. maltophilia group had a steeper decline (-3.2%/year vs. -0.3%/year) in FEV1 compared to the non-infected CF controls (P=0.03). The rate of decline was the same as observed 3years before the patients became chronically infected. Discussions Chronic infection with S. maltophilia does not lead to a steeper decline in lung function when compared to the period before chronic infection.

U2 - 10.1016/j.jcf.2011.03.006

DO - 10.1016/j.jcf.2011.03.006

M3 - Journal article

C2 - 21463972

VL - 10

SP - 318

EP - 325

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - 5

ER -

ID: 40216887